This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glycostem Therapeutics B.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Giuliana Vallanti - Innovator in Cancer Treatment
Introduction
Giuliana Vallanti is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of medicine, particularly in cancer treatment. Her innovative work focuses on the development of Natural Killer (NK) cells, which are crucial in the fight against cancer.
Latest Patents
Giuliana Vallanti holds a patent for a method of manufacturing Natural Killer (NK) cells that are genetically modified with lentiviral vectors. This method involves carrying a polynucleotide coding for Chimeric Antigen Receptors (CARs). The CAR-NK cells produced using this method have shown promise in medical applications, especially in treating cancer.
Career Highlights
Giuliana is associated with Glycostem Therapeutics B.V., where she continues to advance her research and innovations. Her work has the potential to revolutionize cancer therapies and improve patient outcomes.
Collaborations
Giuliana collaborates with notable colleagues, including Catia Traversari and Jan Spanholtz. These partnerships enhance her research and contribute to the development of effective cancer treatments.
Conclusion
Giuliana Vallanti's innovative approach to manufacturing CAR-NK cells represents a significant advancement in cancer treatment. Her contributions to the field are invaluable and hold great promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile